Peripheral Intravascular Ultrasound IVUS Catheter

Peripheral Intravascular Ultrasound IVUS Catheter Market Outlook

The global Peripheral Intravascular Ultrasound (IVUS) Catheter Market is projected to reach approximately USD 1.5 billion by 2035, growing at a CAGR of 5.8% from 2025 to 2035. The market is experiencing significant expansion due to the increasing prevalence of cardiovascular diseases, advancements in imaging technologies, and an enhanced understanding of vascular pathologies. The rising demand for minimally invasive procedures is also a key driver, as IVUS catheters provide real-time imaging, aiding in accurate diagnosis and treatment. Furthermore, growing investments in healthcare infrastructure and the increasing adoption of advanced surgical procedures are expected to propel the market growth. Increased collaborations between healthcare institutions and manufacturers are paving the way for innovative product developments, which will further strengthen the market.

Growth Factor of the Market

The growth of the Peripheral Intravascular Ultrasound IVUS Catheter market is primarily driven by the increasing incidence of cardiovascular disorders, including coronary artery disease and peripheral artery disease. As the global population ages, there is a corresponding rise in health issues related to the cardiovascular system, which significantly enhances the demand for advanced diagnostic tools such as IVUS catheters. Moreover, technological advancements in ultrasound imaging are facilitating the development of more efficient and accurate catheters, further boosting market growth. Another essential factor is the growing preference for minimally invasive procedures among healthcare providers and patients, leading to a shift in focus from traditional surgical methods to advanced imaging techniques. Additionally, the rising awareness of early diagnosis and treatment options for vascular diseases will contribute to market expansion.

Key Highlights of the Market

• The global IVUS catheter market is expected to grow at a CAGR of 5.8% from 2025 to 2035.
• North America holds the largest share of the IVUS catheter market, owing to advanced healthcare infrastructure and high healthcare expenditure.
• Technological advancements in imaging modalities are propelling the development of next-generation IVUS catheters.
• Increased prevalence of cardiovascular diseases is driving demand for diagnostic imaging tools.
• Minimally invasive procedures are becoming more preferred, leading to a growing adoption of IVUS technology.

By Product Type

Monorail IVUS Catheter:

The Monorail IVUS Catheter segment is gaining traction due to its design that allows for easier manipulation and navigation through blood vessels. This type of catheter enables real-time imaging and is often used in conjunction with other interventional devices, enhancing the efficacy of procedures. Monorail catheters provide a single-lumen system which simplifies the introduction of the device into the vascular system. As a result, this catheter type is increasingly favored for its adaptability in various vascular interventions. The growing awareness among healthcare professionals regarding the benefits of Monorail IVUS Catheters is also contributing to this segment's growth.

Over-the-Wire IVUS Catheter:

The Over-the-Wire IVUS Catheter offers distinct advantages, particularly in complex cases where precise positioning is crucial. This catheter type can be advanced over a guide wire, allowing for better control and visualization during procedures. As healthcare providers face increasingly complex vascular anatomies, the demand for Over-the-Wire IVUS Catheters has surged. This segment is particularly popular in the treatment of coronary artery disease, where accurate imaging is vital for successful outcomes. Additionally, advancements in catheter technology are enhancing the performance and reliability of these products, fostering further adoption in clinical setups.

Coronary IVUS Catheter:

The Coronary IVUS Catheter segment is expected to witness significant growth due to the rising prevalence of coronary artery diseases worldwide. These catheters are specifically designed for coronary applications, enabling detailed imaging of coronary arteries and assisting in accurate diagnosis and treatment planning. The increasing number of percutaneous coronary interventions (PCI) and the need for advanced imaging techniques in cardiac procedures are driving demand for these specialized catheters. Moreover, the integration of advanced technologies in coronary imaging, such as three-dimensional imaging capabilities, is further propelling the growth of this market segment.

Peripheral IVUS Catheter:

Peripheral IVUS Catheters are specifically designed for imaging peripheral vascular structures, providing crucial insights into conditions such as peripheral artery disease. This segment is witnessing robust growth driven by the increasing rates of peripheral vascular diseases, which are becoming more prevalent due to lifestyle changes and an aging population. The ability of these catheters to deliver high-resolution images of peripheral arteries aids in accurate disease assessment, leading to timely interventions. As healthcare systems increasingly focus on improving patient outcomes in peripheral vascular treatments, the demand for Peripheral IVUS Catheters is expected to rise significantly.

Other IVUS Catheters:

This category includes various specialized IVUS catheters designed for unique applications or patient needs. Although this segment currently holds a smaller market share compared to other catheter types, it is poised for growth as innovation in catheter technology continues. The development of customized IVUS catheters aimed at specific vascular issues and patient demographics is enabling healthcare providers to enhance their diagnostic capabilities. Furthermore, ongoing research and development in this area are likely to yield new products that address unmet clinical needs, contributing to the overall expansion of the market.

By Application

Peripheral Artery Disease:

The application of IVUS catheters in managing Peripheral Artery Disease (PAD) is critical, as these devices provide valuable diagnostic imaging of blood vessel conditions. The increasing incidence of PAD, often correlated with lifestyle factors and an aging population, is driving the demand for effective imaging solutions. IVUS catheters enable detailed visualization of plaque buildup and arterial blockages, facilitating better decision-making regarding treatment strategies. As awareness of PAD grows among healthcare professionals and patients alike, the utilization of IVUS technology is expected to rise, further bolstering this market segment.

Coronary Artery Disease:

With the rising prevalence of Coronary Artery Disease (CAD) globally, the role of IVUS catheters in this field is becoming increasingly vital. These catheters provide high-resolution imaging that allows cardiologists to assess the extent of arterial plaque and other abnormalities accurately. The integration of IVUS in coronary interventions enhances procedural outcomes by enabling real-time imaging during stent placements and angioplasty. As healthcare systems focus on improving patient outcomes for CAD treatments, the demand for advanced imaging technologies, such as IVUS, is expected to increase significantly over the forecast period.

Atherosclerosis:

Atherosclerosis, a condition characterized by the buildup of fats, cholesterol, and other substances in and on the artery walls, is a significant application for IVUS catheters. These devices are essential for evaluating the severity of atherosclerotic disease and determining the appropriate intervention strategy. The ability of IVUS catheters to provide detailed cross-sectional images of arterial walls aids healthcare providers in understanding the structural changes associated with atherosclerosis. As the prevalence of this condition rises, particularly in aging populations, the market for IVUS catheters is expected to expand, providing clinicians with essential diagnostic tools.

Vascular Imaging:

Vascular imaging is a broad application area for IVUS catheters that encompasses various vascular disorders. These catheters play a crucial role in the detailed assessment of vascular structures, assisting in the diagnosis of conditions beyond just CAD and PAD. The versatility of IVUS technology allows it to be applied in various clinical scenarios, making it an invaluable tool for vascular specialists. As the emphasis on early diagnosis and intervention in vascular diseases increases, the demand for IVUS catheters for vascular imaging applications is projected to grow significantly.

Others:

This category includes additional applications of IVUS catheters across various specialty procedures and research settings. Although this segment currently represents a smaller proportion of the overall market, it is expected to grow as new applications for IVUS technology are explored. Ongoing advancements in imaging techniques and catheter design are likely to uncover new uses for IVUS catheters, further driving innovation in this area. As healthcare providers continue to recognize the benefits of IVUS in diverse applications, this segment will contribute to the overall expansion of the market.

By Distribution Channel

Hospitals:

Hospitals represent a significant distribution channel for Peripheral Intravascular Ultrasound IVUS Catheters, accounting for a substantial share of the market. The integration of advanced imaging technologies in hospitals has led to an increased utilization of IVUS catheters in various cardiovascular procedures. Hospitals are equipped with the necessary infrastructure and trained personnel to handle complex cases that require detailed vascular imaging. Additionally, the rising number of cardiovascular surgeries performed in hospitals is further driving the demand for IVUS technology, making this channel a critical component of the overall market.

Specialty Clinics:

Specialty clinics are gaining prominence as a critical distribution channel for IVUS catheters due to their focus on specific medical disorders, including cardiovascular diseases. These clinics often offer advanced diagnostic and treatment options, utilizing IVUS technology to assist in managing complex vascular conditions. The growing trend of outpatient procedures and an increasing preference for specialized care are driving demand in this segment. As more patients seek treatment at specialty clinics, the role of IVUS catheters in achieving accurate diagnoses and effective treatments is expected to expand.

Ambulatory Surgical Centers:

Ambulatory Surgical Centers (ASCs) are becoming increasingly relevant in the Peripheral IVUS Catheter market. These centers cater to patients requiring same-day surgical procedures, including those that involve vascular interventions. The ability of ASCs to offer advanced imaging techniques, such as IVUS, enhances their appeal for both healthcare providers and patients seeking minimally invasive options. As healthcare systems strive to reduce costs and improve patient outcomes, the utilization of IVUS catheters in ASCs is anticipated to rise significantly, influencing overall market dynamics.

Cath Labs:

Cath Labs serve as another vital distribution channel for IVUS catheters, providing specialized environments for cardiac and vascular procedures. These laboratories are equipped with advanced imaging technologies, making them ideal settings for the utilization of IVUS catheters. As the demand for interventional cardiology procedures increases, the role of Cath Labs in employing IVUS technology for real-time imaging during procedures becomes more pronounced. The focus on enhancing procedural accuracy and patient safety within Cath Labs is expected to drive the growth of this segment in the coming years.

Others:

This category encompasses various distribution channels that contribute to the Peripheral IVUS Catheter market, including online platforms and medical equipment distributors. While this segment currently holds a smaller market share, it is poised for growth as digital healthcare trends gain traction. The convenience of online ordering and the increasing availability of medical supplies through various channels will likely influence the adoption of IVUS catheters in diverse healthcare settings. The expansion of distribution networks and the emphasis on patient accessibility will further drive this segment's growth.

By Material Type

Plastic:

Plastic materials are commonly used in the manufacturing of IVUS catheters due to their flexibility and ease of handling. These materials allow for the creation of lightweight and maneuverable catheters, making them suitable for various vascular applications. The affordability of plastic materials also contributes to their widespread use in catheter production. As manufacturers continue to innovate and improve the performance of plastic-based IVUS catheters, this segment is expected to see sustained growth, particularly in settings where cost-effectiveness is a priority.

Stainless Steel:

Stainless steel is integral to many IVUS catheters, providing durability and resistance to corrosion. This material is particularly beneficial for components that require a high degree of strength and reliability during use. The adoption of stainless steel in IVUS catheter construction is driven by its ability to withstand various procedural demands while ensuring patient safety. As healthcare providers focus on high-quality materials that enhance the longevity and performance of medical devices, the demand for stainless steel IVUS catheters is anticipated to grow.

Nitinol:

Nitinol, a nickel-titanium alloy, is increasingly being utilized in the production of IVUS catheters due to its unique properties, such as flexibility and shape memory. This material is particularly advantageous for catheters used in complex vascular anatomies, as it allows for exceptional navigation and positioning. The adoption of nitinol is expected to rise as manufacturers seek to create more advanced catheters that can conform to various vessel shapes while providing high-resolution imaging. This segment is likely to witness significant growth in line with ongoing advancements in catheter technology.

Silicon:

Silicon is utilized in specific IVUS catheters, particularly those requiring biocompatibility and flexibility. This material enables the creation of catheters that are gentle on the vascular walls, minimizing the risk of trauma during procedures. As awareness of patient safety increases, the preference for biocompatible materials like silicon is expected to rise, fostering growth in this segment. Furthermore, advancements in silicon-based catheter technologies will likely lead to enhanced performance and greater adoption in clinical settings.

Others:

The 'Others' category encompasses additional materials used in the construction of IVUS catheters, including specialized polymers and composites. These materials may be employed in unique applications or specific patient requirements. Although this segment currently represents a smaller portion of the overall market, ongoing research and innovation are likely to expand the use of alternative materials in catheter design. As manufacturers seek to develop products that cater to diverse needs, the growth of this segment is expected to contribute positively to the overall IVUS catheter market.

By Region

The North American region holds the largest share of the Peripheral Intravascular Ultrasound (IVUS) Catheter Market, accounting for approximately 40% of the global market. This dominance can be attributed to the region's advanced healthcare infrastructure, high healthcare expenditure, and a significant number of cardiovascular procedures performed annually. The region also benefits from a strong presence of key market players and ongoing research and development efforts aimed at improving IVUS technology. Furthermore, the rising prevalence of coronary artery diseases in the North American population is expected to drive the demand for IVUS catheters, with a projected CAGR of 6.1% during the forecast period.

Europe follows North America in market share, contributing around 30% to the global IVUS catheter market. The region is witnessing an increase in healthcare spending and investments in advanced medical technologies, including imaging solutions. The presence of a well-established healthcare system and a growing elderly population further drive the demand for IVUS catheters in Europe. Additionally, awareness of early diagnosis and the importance of vascular health is increasing among healthcare providers, leading to a higher adoption of IVUS technology. The Asia Pacific region is projected to experience the highest growth rate, with a CAGR of 7.3%, as countries in this region focus on enhancing healthcare infrastructure and improving access to advanced diagnostic tools.

Opportunities

The Peripheral Intravascular Ultrasound IVUS Catheter market presents several opportunities for growth, particularly in the Asia Pacific region, where there is a rising demand for advanced medical technologies. As countries in this region continue to invest in healthcare infrastructure, there is a significant opportunity for manufacturers to establish a presence and introduce innovative IVUS catheter technologies. Additionally, increasing public awareness about cardiovascular health and the importance of early diagnosis of vascular disorders is creating a favorable market environment. Expanding distribution channels, including e-commerce platforms, can facilitate broader access to IVUS technology, further enhancing market penetration.

Another area of opportunity lies in the development of next-generation IVUS catheters with enhanced imaging capabilities. Advancements in materials and technology can lead to the creation of catheters that provide improved resolution and ease of use. As healthcare providers strive for better patient outcomes, the demand for such innovations will likely increase. Collaborations between manufacturers and healthcare institutions can foster research and development of specialized IVUS catheters designed for specific applications, leading to further growth in this segment. Overall, the market is poised for significant expansion as it adapts to evolving healthcare needs.

Threats

One of the primary threats facing the Peripheral Intravascular Ultrasound IVUS Catheter market is the presence of alternative imaging modalities that may reduce the reliance on IVUS technology. Emerging technologies such as Optical Coherence Tomography (OCT) and Magnetic Resonance Imaging (MRI) are providing healthcare professionals with additional options for vascular imaging. The rapid advancements in these technologies could potentially hinder the growth of the IVUS catheter market if they gain wider acceptance among clinicians. Furthermore, strict regulatory requirements and the need for extensive clinical validation for new products can pose challenges for manufacturers, potentially slowing down the introduction of innovative IVUS solutions into the market.

Another significant restraining factor is the high cost associated with advanced vascular imaging technologies, including IVUS catheters. The expense of these devices can limit their accessibility, especially in developing regions and smaller healthcare facilities. As budget constraints become a more pressing issue for hospitals and clinics, the acceptance of high-priced medical devices may decline. Additionally, the need for skilled personnel to operate advanced imaging equipment could further strain resources in healthcare settings. Addressing these challenges will be crucial for the sustained growth of the IVUS catheter market.

Competitor Outlook

• Boston Scientific Corporation
• Abbott Laboratories
• Medtronic Plc
• Philips Healthcare
• Siemens Healthineers
• Terumo Corporation
• Johnson & Johnson
• Cardiomatics
• Asahi Intecc Co., Ltd.
• Nipro Medical Corporation
• MicroPort Scientific Corporation
• AngioDynamics, Inc.
• iVascular S.L.U.
• ConMed Corporation
• Penumbra, Inc.

The competitive landscape of the Peripheral Intravascular Ultrasound (IVUS) Catheter market is characterized by the presence of several established players and emerging companies. Key players, such as Boston Scientific Corporation and Abbott Laboratories, have a significant market share due to their extensive product portfolios and strong distribution networks. These companies are continuously investing in research and development to introduce innovative IVUS technologies that enhance imaging capabilities and improve patient outcomes. Additionally, collaborations with healthcare providers and institutions are enabling these firms to better understand clinical needs, leading to the development of more tailored solutions.

Medtronic Plc and Philips Healthcare are also notable competitors in the IVUS catheter market, leveraging their technological expertise and established market presence to secure a competitive edge. Medtronic, known for its commitment to advancing cardiovascular care, continues to innovate in imaging technologies to meet the evolving needs of healthcare providers. Philips Healthcare, with its focus on integrated imaging solutions, is well-positioned to capitalize on the growing demand for advanced vascular imaging technologies. The strategic initiatives undertaken by these companies to expand their product offerings and enhance customer satisfaction will be vital in maintaining their competitive positions.

Emerging companies such as iVascular S.L.U. and Cardiomatics are also making their mark in the IVUS catheter market. These firms are focusing on niche applications and developing specialized devices that cater to specific patient populations. By addressing unmet clinical needs and providing cost-effective solutions, these companies are gaining traction and contributing to the overall growth of the market. As the competitive landscape continues to evolve, collaboration, innovation, and a patient-centric approach will be crucial for sustained success in the Peripheral IVUS Catheter market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Cardiomatics
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Medtronic Plc
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Penumbra, Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 iVascular S.L.U.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Johnson & Johnson
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 ConMed Corporation
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Philips Healthcare
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Terumo Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Abbott Laboratories
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 AngioDynamics, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Siemens Healthineers
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Asahi Intecc Co., Ltd.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Nipro Medical Corporation
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Boston Scientific Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 MicroPort Scientific Corporation
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Peripheral Intravascular Ultrasound IVUS Catheter Market, By Application
    • 6.1.1 Peripheral Artery Disease
    • 6.1.2 Coronary Artery Disease
    • 6.1.3 Atherosclerosis
    • 6.1.4 Vascular Imaging
    • 6.1.5 Others
  • 6.2 Peripheral Intravascular Ultrasound IVUS Catheter Market, By Product Type
    • 6.2.1 Monorail IVUS Catheter
    • 6.2.2 Over-the-Wire IVUS Catheter
    • 6.2.3 Coronary IVUS Catheter
    • 6.2.4 Peripheral IVUS Catheter
    • 6.2.5 Other IVUS Catheters
  • 6.3 Peripheral Intravascular Ultrasound IVUS Catheter Market, By Material Type
    • 6.3.1 Plastic
    • 6.3.2 Stainless Steel
    • 6.3.3 Nitinol
    • 6.3.4 Silicon
    • 6.3.5 Others
  • 6.4 Peripheral Intravascular Ultrasound IVUS Catheter Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Specialty Clinics
    • 6.4.3 Ambulatory Surgical Centers
    • 6.4.4 Cath Labs
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Peripheral Intravascular Ultrasound IVUS Catheter Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Peripheral Intravascular Ultrasound IVUS Catheter market is categorized based on

By Product Type

• Monorail IVUS Catheter
• Over-the-Wire IVUS Catheter
• Coronary IVUS Catheter
• Peripheral IVUS Catheter
• Other IVUS Catheters

By Application

• Peripheral Artery Disease
• Coronary Artery Disease
• Atherosclerosis
• Vascular Imaging
• Others

By Distribution Channel

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Cath Labs
• Others

By Material Type

• Plastic
• Stainless Steel
• Nitinol
• Silicon
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Boston Scientific Corporation
• Abbott Laboratories
• Medtronic Plc
• Philips Healthcare
• Siemens Healthineers
• Terumo Corporation
• Johnson & Johnson
• Cardiomatics
• Asahi Intecc Co., Ltd.
• Nipro Medical Corporation
• MicroPort Scientific Corporation
• AngioDynamics, Inc.
• iVascular S.L.U.
• ConMed Corporation
• Penumbra, Inc.